Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

GlaxoSmithKline Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (244)
ARTG (109)
Australian Public Assessment Report (AusPAR) (42)
Prescription medicine registration (22)
Designation or determination (5)
Prescription medicine decision summary (4)
Prescription medicine evaluation (3)
Face mask cancellation (1)

Date

2026 (7)
2025 (25)
2024 (13)
2023 (18)
2022 (61)
2021 (12)
2020 (59)
2019 (30)
2018 (27)
2017 (24)
2016 (11)
2015 (49)
2014 (21)
2013 (9)
2012 (6)
2011 (4)
2010 (7)
2009 (3)
2008 (6)
2007 (4)
2006 (3)
2005 (4)
2004 (1)
2003 (3)
2002 (1)
2001 (1)
2000 (3)
1999 (1)
1998 (5)
1997 (4)
1995 (1)
1991 (6)

Search

Sponsor content

430 result(s) found, displaying 301 to 310

WARTEC SOLUTION podophyllotoxin 5mg/mL bottle (reformulation) Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
ZOVIRAX ACICLOVIR 800mg tablet bottle Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
ZOVIRAX aciclovir 400mg dispersible tablet bottle Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
ZOVIRAX COLD SORE CREAM aciclovir 5% cream tube Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
AVANDAMET 1/500 tablet blister pack Cancelled under s30(1)(c) of the Act

6 March 2017

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
OROXINE THYROXINE SODIUM 50 microgram tablet - uncoated bottle Cancelled under s30(1)(c)

8 December 2016

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
OROXINE Thyroxine sodium 100 microgram tablet - uncoated bottle Cancelled under s30(1)(c)

8 December 2016

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
OROXINE Thyroxine sodium 200 microgram tablet - uncoated bottle Cancelled under s30(1)(c)

8 December 2016

Cancellation by sponsor

Requested by GlaxoSmithKline Australia Pty Ltd
BENLYSTA belimumab 120 mg powder for injection vial (173077)

18 October 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BENLYSTA belimumab 120 mg powder for injection vial.
BENLYSTA belimumab 400 mg powder for injection vial (173078)

18 October 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BENLYSTA belimumab 400 mg powder for injection vial.

Pages

First page
Previous page
…
Page 27
Page 28
Page 29
Page 30
Current page 31
Page 32
Page 33
Page 34
Page 35
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.